These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 2938849)

  • 1. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
    FitzGerald GA; Brash AR; Oates JA; Pedersen AK
    J Clin Invest; 1983 Oct; 72(4):1336-43. PubMed ID: 6355181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
    Fitzgerald DJ; Fragetta J; FitzGerald GA
    J Clin Invest; 1988 Nov; 82(5):1708-13. PubMed ID: 3183064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
    Henriksson P; Rasmanis G; Edhag O; Vesterqvist O; Gréen K
    Prostaglandins; 1990 Jan; 39(1):99-107. PubMed ID: 2106716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA; Reilly IA; Pedersen AK
    Circulation; 1985 Dec; 72(6):1194-201. PubMed ID: 3905048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
    Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA
    N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man.
    MacNab MW; Foltz EL; Graves BS; Rinehart RK; Tripp SL; Feliciano NR; Sen S
    J Clin Pharmacol; 1984; 24(2-3):76-83. PubMed ID: 6371062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
    Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
    Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.
    Praticò D; Cyrus T; Li H; FitzGerald GA
    Blood; 2000 Dec; 96(12):3823-6. PubMed ID: 11090066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
    Hoet B; Falcon C; De Reys S; Arnout J; Deckmyn H; Vermylen J
    Blood; 1990 Feb; 75(3):646-53. PubMed ID: 2153424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.